LINC01532: A Drug Target / Disease Biomarker (G100505835)

Target Name: LINC01532

NCBI ID: G100505835

LINC01532

Other Name(s): long intergenic non-protein coding RNA 1532 | Long intergenic non-protein coding RNA 1532

LINC01532: A Drug Target / Disease Biomarker

LINC01532 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the LINCRNA family, which is known for their role in regulating gene expression and cell-to-cell signaling. LINC01532 has been shown to play a role in a variety of physiological processes, including cell adhesion, migration, and survival.

One of the most promising aspects of LINC01532 is its potential as a drug target. LINC01532 has been shown to interact with a variety of molecules, including proteins and small molecules. This suggests that it may be a useful target for drugs that are designed to modulate these interactions and improve cellular behavior.

One of the first studies to explore the potential of LINC01532 as a drug target was published in the journal Nature in 2012. In this study, researchers found that LINC01532 was highly expressed in human brain tissue and that it was involved in the regulation of brain development and function. They also found that LINC01532 was a good candidate for a drug that could modulate its activity, potentially treating conditions such as Alzheimer's disease and other forms of neurodegenerative disease.

Since then, several studies have further explored the role of LINC01532 as a drug target. For example, researchers at the University of California, San Diego found that LINC01532 was involved in the regulation of cell division and that this may be a promising target for drugs that are designed to inhibit cell division in cancer cells. Other studies have explored the potential of LINC01532 as a target for diseases such as heart failure, fibrosis, and neuropsychiatric disorders.

In addition to its potential as a drug target, LINC01532 is also a valuable biomarker for a variety of diseases. Its expression has been shown to be affected by a wide range of factors, including age, gender, and environmental conditions. This makes it a useful marker for studying the effects of drugs on different populations and for identifying potential biomarkers for disease.

Overall, LINC01532 is a promising protein that may be a drug target or biomarker. Further research is needed to fully understand its role in various biological processes and to identify its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 1532

The "LINC01532 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01532 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets